Successful treatment of primary non-Hodgkin's lymphoma of the vagina with chemotherapy

Arch Gynecol Obstet. 2004 Mar;269(3):208-10. doi: 10.1007/s00404-002-0350-3. Epub 2003 Aug 5.

Abstract

Introduction: The vagina as a primary site of malignant lymphoma in woman is extremely rare.

Case report: We report here a 30-year-old patient with a primary vaginal non-Hodgkin's lymphoma stage IEA, follicular large cell of B lineage, with an excellent response to cytotoxic chemotherapy (CHOP) and event-free survival of 28 months.

Conclusion: Primary involvement of the vagina can be successfully treated by pelvic irradiation, but in young women chemotherapy should be considered to preserve fertility, as well as quality of life.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cyclophosphamide / administration & dosage
  • Diagnosis, Differential
  • Doxorubicin / administration & dosage
  • Female
  • Humans
  • Lymphoma, Follicular / diagnosis*
  • Lymphoma, Follicular / drug therapy*
  • Prednisone / administration & dosage
  • Vaginal Neoplasms / diagnosis*
  • Vaginal Neoplasms / drug therapy*
  • Vincristine / administration & dosage

Substances

  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone

Supplementary concepts

  • CHOP protocol